STK11 gene modulator (Recursion)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSTK11 gene modulator (Recursion)
Drug Alias Nameserine/threonine kinase-11 gene modulator (Recursion)repurposed therapeutics (Recursion)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase STK11 modulators
TargetsSerine/threonine-protein kinase STK11
Therapy Area/IndicationsPeutz-Jeghers Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRecursion Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRecursion Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPeutz-Jeghers Syndrome

Other Information

ATC CodeN/A
Related LinksN/A